BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ALR Technologies Inc. Announces Election of New Board Member and Appointment of Chief Commercial Officer


1/2/2013 8:50:19 AM

RICHMOND, VA--(Marketwire - December 31, 2012) - ALR Technologies Inc. (OTCBB: ALRT) (the "Company"), a health information technology developer, is pleased to announce the election of William S. Smith to the Board of Directors and the appointment of Mr. Smith as Chief Commercial Officer, effective January 1, reporting to CEO Sidney Chan. Mr. Smith will oversee sales and marketing, investor relations, public affairs and communications, and government affairs.

Mr. Smith was most recently Managing Director, Healthcare at NSI, LLC, a Washington, D.C.-based consulting firm where Mr. Smith advised pharmaceutical, biotechnology and medical device companies including AstraZeneca, MedImmune, Merck, UCB, and Genzyme. Prior to NSI, Mr. Smith worked for a decade at Pfizer Inc. where he was Vice President of U.S. Public Affairs and Policy. In that role, Smith was the lead advisor on U.S. policy issues to Pfizer's major commercial businesses in the United States. Smith had previously worked in government where he was on the staff of two Governors in Massachusetts, was a leadership aide to the Republican Leadership in the U.S. House of Representatives, and was a senior aide in the White House Office of National Drug Control Policy under President George H.W. Bush.

"I am delighted to welcome Mr. Smith to ALR Technologies," said ALRT CEO Sidney Chan. "He has deep experience in the healthcare marketplace and he has significant experience building and leading a large organization. As a consultant, he provided ALRT with invaluable strategic counsel on our key markets and business model. As we now enter the commercial phase of our key product, he will build a world class organization to support our growth."

"I am very excited to join ALR Technologies," said Mr. Smith. "The company has developed a technology and a business model that is precisely in the space where healthcare is going. The company has huge potential for growth and its future success would represent a great opportunity for patients with diabetes to better control their condition."

About ALR Technologies Inc.

ALRT Health-e-Connect System ("System") is the principal product of the Company. Heath-e-Connect is a web based patient management platform for medical professionals to improve compliance and adherence of care plans of patients in their homes. The System is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. More information on ALR Technologies and its products can be found at http://www.alrt.com.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.


ALR Technologies:
804-554-3500 Ext. 704
e-mail: contact@alrt.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES